Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Phospholipid (Survanta Beractant)
Connect with this vendor - Learn about this product

Phospholipid (Survanta Beractant)

Each ml contains 25 mg phospholipids.
Beractant is indicated for prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants.

  • Import License: FF-535-25230
  • Presentation: Sterile Suspension
  • Strength:  25 mg  
  • Pack Size: 8 ml bottle
  • Pack Insert: NA
  • Marketing Authorization Holder: Abbott India